Wu, J., Clingen, P. H., Spanswick, V. J., Mellinas-Gomez, M., Meyer, T., Puzanov, I., . . . Hartley, J. A. (2012). γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: Results from two Phase I clinical trials of SJG-136 (SG2000). Clin Cancer Res.
Citación estilo ChicagoWu, Jenny, Peter H. Clingen, Victoria J. Spanswick, Maria Mellinas-Gomez, Tim Meyer, Igor Puzanov, Duncan Jodrell, Daniel Hochhauser, y John A. Hartley. "γ-H2AX Foci Formation As a Pharmacodynamic Marker of DNA Damage Produced By DNA Cross-linking Agents: Results From Two Phase I Clinical Trials of SJG-136 (SG2000)." Clin Cancer Res 2012.
Cita MLAWu, Jenny, et al. "γ-H2AX Foci Formation As a Pharmacodynamic Marker of DNA Damage Produced By DNA Cross-linking Agents: Results From Two Phase I Clinical Trials of SJG-136 (SG2000)." Clin Cancer Res 2012.